GleamWall
中文EN

ADGM Adagio Medical Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2006986 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE9.6%
ROA2.7%
ROIC (approx.)-89.9%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets38.5%
Debt / equity0.11x
Current ratio0.90x
Interest coverage-5.77x

Cash quality & payout

Operating cash flow / net income-22.06x
Accruals ratio61.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$0—
Cost of revenue$684,000—
Gross profit-$684,000—
R&D expense$10.64M—
SG&A expense$10.57M—
Operating income-$21.89M—
Interest expense$2.91M—
Pretax income-$25.32M—
Income tax$0$0
Net income-$25.08M—
EBITDA-$20.92M—
EPS (basic)-1.51—
EPS (diluted)-1.51—
Weighted avg. shares (diluted)16.58M—
Balance sheet
Cash & equivalents$17.11M$20.59M
Receivables—$35,000
Inventory$1.67M$2.57M
Current assets$20.08M$25.35M
PP&E, net$1.53M$1.96M
Goodwill$13.97M$13.97M
Intangibles$6.97M$6.97M
Total assets$43.25M$48.45M
Current liabilities$8.23M$7.76M
Long-term debt$21.04M$17.18M
Total debt$21.04M$17.18M
Total liabilities$30.85M$28.54M
Shareholders' equity$12.40M$19.91M
Net debt$3.94M-$3.41M
Shares outstanding740,34815.20M
Cash flow statement
Operating cash flow-$19.01M—
Capital expenditure$374,000—
Free cash flow-$19.39M—
Investing cash flow-$374,000—
Financing cash flow$16.13M—
Depreciation & amortization$970,000—
Stock-based compensation$1.48M—

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.